Pharmacokinetics, biodistribution, and activity of Amphotericin B-loaded nanocochleates on the Leishmania donovani murine visceral leishmaniasis model-Reference-Cited by-同舟云学术

Pharmacokinetics, biodistribution, and activity of Amphotericin B-loaded nanocochleates on the Leishmania donovani murine visceral leishmaniasis model

Published:2022-08 Issue: Volume:624 Page:121985
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Lipa Castro Antonio,Pomel Sébastien,Cailleau Catherine,Fournier Natalie,Dennemont Indira,Loiseau Philippe M.,Barratt Gillian^ORCID

Funder

Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference30 articles.

1. Encochleated Amphotericin B: is the oral availability of Amphotericin B finally reached?;Aigner;J. Fungi,2020

2. In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route;Balaraman;Biomed. Pharmacother.,2015

3. Recent Developments in Leishmaniasis: Epidemiology, Diagnosis, and Treatment;Berman;Curr. Infect. Disease Reports,2005

4. Dispersion and stabilization of cochleate nanoparticles;Bozó;Eur. J. Pharm. Biopharm.,2017

5. Antileishmanial activity of a formulation of 2-n-propylquinoline by oral route in mice model;Campos Vieira;Parasite,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Leishmaniasis Treatment with Cutting Edge Drug Delivery Systems and Nanovaccines: An Updated Review;ACS Infectious Diseases;2024-06-03

2. Current development of a lipid-based nanocochleates containing Amphotericin B for oral administration;Journal of Drug Delivery Science and Technology;2024-02

3. Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations;Pharmaceutics;2022-12-28

4. Review of Novel Oral Amphotericin B Formulations for the Treatment of Parasitic Infections;Pharmaceutics;2022-10-28